Jul 8, 2014
Biotech reels over patent ruling
Guidelines that forbid patents on a wide array of natural products, phenomena and principles have many in the biotechnology and pharmaceutical industries worried about the future of their business.
Prometheus Laboratories Inc. Release: PROCLAIM Patient Registry Data...
Prometheus Laboratories Inc. Release: PROCLAIM Patient Registry Data Show Extension Of Overall Survival Benefits Beyond Complete And Partial Responders In Metastatic Renal Cell Carcinoma Patients Treated With High-Dose Interleukin-2 PROCLAIM Patient Registry Data Show Extension of Overall Survival Benefits Beyond Complete and Partial Responders in ... (more)
Gensignia Appoints CEO
Gensignia appoints CEO LONDON, UK, and SAN DIEGO, USA - May 30, 2014 A - Gensignia Ltd, a London-based privately held microRNA company, has appointed Lee McCracken as Chief Executive Officer of its wholly owned subsidiary, Gensignia Life Sciences, Inc. Mr McCracken will lead San Diego based Gensignia Life Sciences, Inc. to advance the company's ... (more)
Public-private partnership formed to uncover what triggers bowel diseases
Janssen Research & Development said Monday it is establishing a public-private consortium that will seek to identify the biological triggers that cause, or lead to the development, of inflammatory bowel disease.